Latest Institutional Purchases of Xenon Pharmaceuticals Inc. (XENE)
This list provides information on the latest institutional transactions involving Xenon Pharmaceuticals Inc. (XENE) stock that were buys. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the purchase has occurred.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
BUY
|
- |
26.2K+ 12.36% |
$1M - $1.2M
|
239K
$9.35M
|
|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
BUY
|
- |
5.58K+ 72.28% |
$213K - $255K
|
13.3K
$521K
|
|
Jan 13, 2025
Q4 2024
|
Elmwood Wealth Management, Inc.
|
BUY
|
- |
3.4K+ 44.7% |
$130K - $156K
|
11K
$431K
|
|
Jan 17, 2025
Q4 2024
|
Nelson, Van Denburg & Campbell Wealth Management Group, LLC
Omaha, NE |
BUY
|
- |
2.57KNew |
$98K - $118K
|
2.57K
$101K
|
|
Jan 10, 2025
Q4 2024
|
Harbor Capital Advisors, Inc.
|
BUY
|
- |
1.76K+ 3.65% |
$66.9K - $80.3K
|
49.8K
$1.95M
|
|
Jan 22, 2025
Q4 2024
|
Ronald Blue Trust, Inc.
Brentwood, TN |
BUY
|
- |
1.41K+ 140.28% |
$53.9K - $64.7K
|
2.42K
$94.9K
|
|
Jan 22, 2025
Q4 2024
|
Kbc Group Nv
|
BUY
|
- |
780+ 39.76% |
$29.7K - $35.7K
|
2.74K
$107K
|
|
Q3 2024 | |||||||
Nov 14, 2024
Q3 2024
|
Janus Henderson Group PLC
London, X0 |
BUY
|
- |
1.51M+ 144.19% |
$54.4M - $66.3M
|
2.55M
$100M
|
|
Dec 26, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
905K+ 1263.19% |
$32.7M - $39.8M
|
977K
$38.3M
|
|
Nov 13, 2024
Q3 2024
|
Siren, L.L.C.
New York, NY |
BUY
|
- |
744KNew |
$26.9M - $32.7M
|
744K
$29.1M
|
|
Nov 14, 2024
Q3 2024
|
Samlyn Capital, LLC
New York, NY |
BUY
|
- |
381K+ 59.49% |
$13.7M - $16.7M
|
1.02M
$40M
|
|
Nov 14, 2024
Q3 2024
|
Vestal Point Capital, LP
New York, NY |
BUY
|
- |
300K+ 57.14% |
$10.8M - $13.2M
|
825K
$32.3M
|
|
Nov 14, 2024
Q3 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
BUY
|
- |
244K+ 13.29% |
$8.83M - $10.7M
|
2.08M
$81.7M
|
|
Nov 14, 2024
Q3 2024
|
Driehaus Capital Management LLC
Chicago, IL |
BUY
|
- |
176K+ 3.99% |
$6.37M - $7.75M
|
4.6M
$180M
|
|
Nov 12, 2024
Q3 2024
|
Bio Impact Capital LLC
Cambridge, MA |
BUY
|
- |
166KNew |
$5.99M - $7.29M
|
166K
$6.5M
|
|
Nov 13, 2024
Q3 2024
|
Affinity Asset Advisors, LLC
New York, NY |
BUY
|
- |
150K+ 15.07% |
$5.41M - $6.58M
|
1.14M
$44.8M
|
|
Nov 14, 2024
Q3 2024
|
Braidwell LP
Stamford, CT |
BUY
|
- |
147K+ 5.73% |
$5.3M - $6.45M
|
2.71M
$106M
|
|
Nov 13, 2024
Q3 2024
|
Capital International Investors
Los Angeles, CA |
BUY
|
- |
105K+ 4.25% |
$3.8M - $4.63M
|
2.58M
$101M
|
|
Nov 14, 2024
Q3 2024
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
- |
105KNew |
$3.79M - $4.61M
|
105K
$4.11M
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
95.5K+ 26.21% |
$3.45M - $4.2M
|
460K
$18M
|
|
Nov 13, 2024
Q3 2024
|
Schroder Investment Management Group
London, X0 |
BUY
|
- |
85.2K+ 93.09% |
$3.08M - $3.74M
|
177K
$6.92M
|
|
Nov 14, 2024
Q3 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
BUY
|
- |
66.4KNew |
$2.4M - $2.92M
|
66.4K
$2.6M
|
|
Nov 14, 2024
Q3 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
64.8K+ 31.02% |
$2.34M - $2.85M
|
274K
$10.7M
|
|
Nov 14, 2024
Q3 2024
|
Avidity Partners Management LP
Dallas, TX |
BUY
|
- |
64K+ 8.49% |
$2.31M - $2.81M
|
818K
$32.1M
|
|
Nov 14, 2024
Q3 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
BUY
|
- |
63.9K+ 4.44% |
$2.31M - $2.81M
|
1.5M
$58.9M
|
|
Nov 13, 2024
Q3 2024
|
Russell Investments Group, Ltd.
|
BUY
|
- |
60.8K+ 37.31% |
$2.19M - $2.67M
|
224K
$8.76M
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
50.4KNew |
$1.82M - $2.22M
|
50.4K
$1.98M
|
|
Nov 12, 2024
Q3 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
BUY
|
- |
49.3K+ 3.33% |
$1.78M - $2.17M
|
1.53M
$59.9M
|
|
Nov 14, 2024
Q3 2024
|
Orbimed Advisors LLC
San Diego, CA |
BUY
|
- |
49.1K+ 5.69% |
$1.77M - $2.16M
|
911K
$35.7M
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
48.5K+ 24.83% |
$1.75M - $2.13M
|
244K
$9.55M
|
|
Nov 13, 2024
Q3 2024
|
Loomis Sayles & CO L P
|
BUY
|
- |
47K+ 7.11% |
$1.7M - $2.06M
|
707K
$27.7M
|
|
Nov 14, 2024
Q3 2024
|
Rock Springs Capital Management LP
Baltimore, MD |
BUY
|
- |
43.6K+ 3.43% |
$1.57M - $1.92M
|
1.32M
$51.6M
|
|
Nov 14, 2024
Q3 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
BUY
|
- |
43.2K+ 26.69% |
$1.56M - $1.9M
|
205K
$8.03M
|
|
Nov 14, 2024
Q3 2024
|
Ally Bridge Group (Ny) LLC
New York, NY |
BUY
|
- |
42.4K+ 25.05% |
$1.53M - $1.86M
|
212K
$8.3M
|
|
Nov 12, 2024
Q3 2024
|
Algert Global LLC
San Francisco, CA |
BUY
|
- |
36.4K+ 19.89% |
$1.32M - $1.6M
|
220K
$8.61M
|
|
Oct 24, 2024
Q3 2024
|
Abrdn PLC
|
BUY
|
- |
35.8K+ 16.85% |
$1.29M - $1.57M
|
248K
$9.73M
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
33.4K+ 19.05% |
$1.21M - $1.47M
|
209K
$8.19M
|
|
Nov 14, 2024
Q3 2024
|
State Street Corp
Boston, MA |
BUY
|
- |
32.7K+ 13.25% |
$1.18M - $1.44M
|
280K
$11M
|
|
Nov 05, 2024
Q3 2024
|
Gsa Capital Partners LLP
London, X0 |
BUY
|
- |
30.8K+ 475.92% |
$1.11M - $1.36M
|
37.3K
$1.46M
|
|
Nov 14, 2024
Q3 2024
|
Pfm Health Sciences, LP
San Francisco, CA |
BUY
|
- |
29.3K+ 19.48% |
$1.06M - $1.29M
|
180K
$7.05M
|
|
Nov 12, 2024
Q3 2024
|
Westfield Capital Management CO LP
Boston, MA |
BUY
|
- |
26.1K+ 4.05% |
$941K - $1.15M
|
670K
$26.2M
|
|
Nov 04, 2024
Q3 2024
|
Times Square Capital Management, LLC
|
BUY
|
- |
23.8K+ 3.15% |
$860K - $1.05M
|
778K
$30.5M
|
|
Nov 14, 2024
Q3 2024
|
Adar1 Capital Management, LLC
Austin, TX |
BUY
|
- |
23.2K+ 493.68% |
$838K - $1.02M
|
27.9K
$1.09M
|
|
Nov 08, 2024
Q3 2024
|
Bnp Paribas Asset Management Holding S.A.
|
BUY
|
- |
18K+ 4.26% |
$648K - $789K
|
439K
$17.2M
|
|
Nov 14, 2024
Q3 2024
|
Wellington Management Group LLP
Boston, MA |
BUY
|
- |
15.2K+ 0.4% |
$550K - $669K
|
3.84M
$151M
|
|
Nov 12, 2024
Q3 2024
|
Nicholas Investment Partners, LP
Rancho Santa Fe, CA |
BUY
|
- |
14.7KNew |
$529K - $644K
|
14.7K
$574K
|
|
Nov 15, 2024
Q3 2024
|
Barclays PLC
London, X0 |
BUY
|
- |
13.9K+ 1275.5% |
$502K - $611K
|
15K
$588K
|
|
Nov 12, 2024
Q3 2024
|
Fox Run Management, L.L.C.
Greenwich, CT |
BUY
|
- |
13.1K+ 195.26% |
$472K - $574K
|
19.7K
$774K
|
|
Nov 14, 2024
Q3 2024
|
Brevan Howard Capital Management LP
St. Helier, Y9 |
BUY
|
- |
12KNew |
$434K - $528K
|
12K
$471K
|
|
Nov 14, 2024
Q3 2024
|
Paul Tudor Jones
Tudor Investment Corp Et Al | Stamford, Ct
|
BUY
|
- |
11.5K+ 45.4% |
$414K - $504K
|
36.7K
$1.44M
|